MediPal Holdings Corporation
7459
Clasificación en acciones
#4259
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Precio por acción
$20.47
Capitalización bursátil
$3.73B
Cambio (1 día)
-0.57%
Cambio (1 año)
23.25%
País
JP
Comercio MediPal Holdings Corporation (7459)
Categoría
Healthcare
Ratio P/E de MediPal Holdings Corporation (7459)
Ratio P/E al October 2026 TTM: 13.55
Según los últimos informes financieros y el precio de las acciones de MediPal Holdings Corporation, el P/E actual (TTM) de la empresa es 13.55. Al final de 2024, la empresa tenía un P/E de 11.83.
Historial del ratio P/E de MediPal Holdings Corporation desde 2005 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 13.55 | 12.11% |
| 2025 | 12.09 | 2.20% |
| 2024 | 11.83 | 21.17% |
| 2023 | 9.76 | -32.12% |
| 2022 | 14.38 | -22.86% |
| 2021 | 18.64 | 62.38% |
| 2020 | 11.48 | -37.22% |
| 2019 | 18.28 | 29.27% |
| 2018 | 14.14 | 3.79% |
| 2017 | 13.63 | 3.92% |
| 2016 | 13.11 | -12.25% |
| 2015 | 14.94 | 6.79% |
| 2014 | 13.99 | -9.39% |
| 2013 | 15.44 | -28.55% |
| 2012 | 21.62 | -78.66% |
| 2011 | 101.31 | -23.98% |
| 2010 | 133.28 | 563.24% |
| 2009 | 20.09 | 32.62% |
| 2008 | 15.15 | -44.08% |
| 2007 | 27.10 | 41.90% |
| 2006 | 19.09 | -36.81% |
| 2005 | 30.21 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 26.02 | 91.98% |
US
|
|
| - | - |
US
|
|
| 34.08 | 151.42% |
US
|
|
| - | - |
US
|
|
| 45.62 | 236.56% |
AU
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.